Related Experiment Video
Updated: Jun 25, 2026

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
Published on: May 15, 2021
Effects of pentoxifylline on amikacin-induced nephrotoxicity in rats
Mehmet Kaya Ozer1, Halil Asci, Meral Oncu
1Department of Pharmacology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey. mkozer1971@yahoo.com
Abstract:
The nephrotoxicity of amikacin (AK) was prevented with pentoxifylline (PTX) in a rat model. Rats were received a single injection of AK (1.2 g/kg, i.p.) with or without PTX pretreatment (25 mg/kg, orally). Renal morphology was investigated by light microscopy. Tissue samples and trunk blood were also obtained to determine renal malondialdehyde (MDA), blood urea nitrogen (BUN), and creatinine (Cr) levels. MDA production was found to be higher in AK group. PTX administration caused a significant decrease in MDA production. Morphological damage in rats given AK was severe in the kidney, whereas in rats given AK plus PTX, no histological changes occurred. It is concluded that PTX could be useful for reducing the nephrotoxic effects of AK.
Insights
Pentoxifylline (PTX) effectively prevented amikacin (AK) induced nephrotoxicity in rats. PTX pretreatment significantly reduced kidney damage and oxidative stress markers, indicating its protective potential against AK side effects.
Area of Science:
- Pharmacology and Toxicology
- Nephrology
- Biochemistry
Background:
- Amikacin (AK) is an aminoglycoside antibiotic with known nephrotoxic potential.
- Oxidative stress plays a significant role in aminoglycoside-induced kidney damage.
- Pentoxifylline (PTX) is a hemorheologic agent with anti-inflammatory and antioxidant properties.
Purpose of the Study:
- To investigate the protective effect of pentoxifylline (PTX) against amikacin (AK) induced nephrotoxicity in a rat model.
- To evaluate the impact of PTX on renal oxidative stress markers and kidney morphology following AK administration.
Main Methods:
- Rats received a single intraperitoneal injection of amikacin (1.2 g/kg) with or without oral pentoxifylline pretreatment (25 mg/kg).
- Renal morphology was assessed using light microscopy.
- Levels of malondialdehyde (MDA), blood urea nitrogen (BUN), and creatinine (Cr) were measured in kidney tissue and blood.
Main Results:
- Amikacin administration led to significantly elevated levels of malondialdehyde (MDA), a marker of oxidative stress.
- Pentoxifylline pretreatment markedly reduced MDA production in the kidneys.
- Severe morphological damage was observed in the kidneys of rats treated with amikacin alone, while co-administration with pentoxifylline prevented these histological changes.
Conclusions:
- Pentoxifylline demonstrates significant nephroprotective effects against amikacin-induced kidney injury in rats.
- The protective mechanism of PTX may involve the reduction of oxidative stress.
- Pentoxifylline holds potential as an adjunct therapy to mitigate the nephrotoxic side effects of amikacin.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Acute Kidney Injury II: Pathophysiology
Drug Toxicity: Dose-Dependent Reactions
Physical Properties of Amines
